Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 45 Glioma 16 Neuroblastoma 15 Brain Neoplasms 14 Astrocytoma 10 Neoplasms 8 Rhabdomyosarcoma 7 Sarcoma, Ewing 6 Recurrence 5 Oligodendroglioma 5 Medulloblastoma 5 Sarcoma 4 Osteosarcoma 4 Melanoma 4 Small Cell Lung Carcinoma 3 Neuroendocrine Tumors 3 Neuroectodermal Tumors, Primitive 3 Lymphoma 3 Gliosarcoma 3 Diffuse Intrinsic Pontine Glioma 3 Wilms Tumor 2 Rhabdoid Tumor 2 Pyloric Stenosis, Hypertrophic 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Ganglioneuroblastoma 2 Fallopian Tube Neoplasms 2 Ependymoma 2 Colorectal Neoplasms 2 Central Nervous System Neoplasms 2

Interventions

Sirolimus 2 Therapeutic Touch 1 Temozolomide 1 Sulfasalazine 1 Radiotherapy 1 Memantine 1 Medical Marijuana 1 Magnetoencephalography 1 Gabapentin 1 Clinical Laboratory Techniques 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Epilepsy × Temozolomide × Clear all

NCT05664464 2024-05-10

GLUGLIO

University of Zurich

Phase 1/2 Recruiting

Epilepsy, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡